Millennium Management’s Bionano Genomics BNGO Stock Holding History

Millennium Management’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$876K	–	6388
2022 Q4	$876K	Sell	1,000 -600	-38%	-$755K	﹤0.01%	4290
2022 Q3	$1.76M	Buy	+1,600	New	+$2.11M	﹤0.01%	3861
2021 Q4	–	Sell	-500	Closed	-$1.65M	–	6803
2021 Q3	$1.65M	Hold	500	–	–	﹤0.01%	4134
2021 Q2	$2.2M	Buy	+500	New	+$1.97M	﹤0.01%	3847

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Millennium Management's BNGO Position: Q1 2025 in Review

Millennium Management sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 167 shares — an estimated $2.88K sold.

Millennium Management first reported a position in BNGO in Q4 2018 and held it in 18 quarters. The position peaked at $23.4M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

Millennium Management reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 167 Bionano Genomics shares in Q1 2025, an estimated $2.88K.
Millennium Management first reported a position in Bionano Genomics in Q4 2018 and held it in 18 quarters.
Millennium Management's Bionano Genomics position peaked at $23.4M in Q2 2021.
30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.